Overview

Sustained Mood Improvement With Laughing Gas Exposure

Status:
NOT_YET_RECRUITING
Trial end date:
2028-09-01
Target enrollment:
Participant gender:
Summary
Multi-centre, parallel group, blinded, 1:1 randomized controlled trial to determine the effect of nitrous oxide on reducing symptoms of depression in patients with treatment resistant depression.
Phase:
PHASE3
Details
Lead Sponsor:
Women's College Hospital
Collaborators:
Anesthesia Clinical Trials Unit (Department of Anesthesia and Pain Management)
Canadian Institutes of Health Research (CIHR)
Sunnybrook Health Sciences Centre
Unity Health Toronto
University Health Network, Toronto
Treatments:
Midazolam
Nitrous Oxide